Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen.
about
The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanismsThe insulin-like growth factor-I receptor (IGF-IR) in breast cancer: biology and treatment strategies.Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes.The role of the insulin-like growth factor-1 system in breast cancerInsulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance.Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancerRevealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis.Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)Association between IRS1 Gene Polymorphism and Autism Spectrum Disorder: A Pilot Case-Control Study in Korean Males.Non-coding single nucleotide variants affecting estrogen receptor binding and activityFunctional IGF1R variant predicts breast cancer risk in women with preeclampsia in California Teachers Study.The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysisSingle nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial.Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer.Association of increased primary breast tumor AGR2 with decreased disease-specific survival.
P2860
Q27026813-6BE9D114-A018-4CEE-B7A2-638735AF8AEAQ30244095-9164CA82-A8BD-4423-909E-4E34673E2C07Q34904277-8B7ADA9E-FA29-4E5B-BFDA-54E5AAE4A732Q35105295-F844DA10-DD2B-4A97-9FE6-DB9CEC79F2A3Q35606589-B1CAA509-2392-42D0-B032-3F6BCDBA1149Q35678104-97B54B12-00C6-41EA-9F5C-6499A96167B1Q35876634-AA385CBC-E106-4545-AEA0-B77E3338814CQ36433403-21A83AAD-5F26-409B-AA1B-E5DC74547BBDQ37209924-824290FB-BDE8-4A92-BED9-0B3D39FC8AC5Q37498825-CFCF706A-7B74-4EEA-8A3D-C656391598E4Q38640174-4C9F344C-6A83-4E63-8A77-3FE0515D9011Q41019747-96D930C5-D7D4-4ECE-BFF6-88E1654FBC21Q46300809-88CDE777-708D-4A19-99DF-27E2BE23AB86Q46776621-1C822F9A-D4A6-485A-987C-A780D45C826DQ55378163-A3228FE0-B310-4401-A357-B7937E0877AB
P2860
Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Insulin-like growth factor rec ...... tients treated with tamoxifen.
@en
Insulin-like growth factor rec ...... tients treated with tamoxifen.
@nl
type
label
Insulin-like growth factor rec ...... tients treated with tamoxifen.
@en
Insulin-like growth factor rec ...... tients treated with tamoxifen.
@nl
prefLabel
Insulin-like growth factor rec ...... tients treated with tamoxifen.
@en
Insulin-like growth factor rec ...... tients treated with tamoxifen.
@nl
P2093
P2860
P356
P1476
Insulin-like growth factor rec ...... atients treated with tamoxifen
@en
P2093
J Stebbing
P M Wilson
P2860
P2888
P356
10.1038/TPJ.2013.8
P577
2013-03-05T00:00:00Z